Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
Provided By GlobeNewswire
Last update: Jul 16, 2024
WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical Officer.
